Chemoinformaics analysis of 2-Hydroxypentan-3-one
| Molecular Weight | 102.133 | nRot | 2 |
| Heavy Atom Molecular Weight | 92.053 | nRig | 7 |
| Exact Molecular Weight | 102.068 | nRing | 0 |
| Solubility: LogS | -5.375 | nHRing | 0 |
| Solubility: LogP | 4.853 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 16.6219 |
| nHD | 1 | BPOL | 10.9001 |
| QED | 0.22 |
| Synth | 4.112 |
| Natural Product Likeliness | 2.37 |
| NR-PPAR-gamma | 0.924 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.165 |
| MDCK | 0.000027 |
| BBB | 0.007 |
| PPB | 1.01112 |
| VDSS | 2.581 |
| FU | 0.010518 |
| CYP1A2-inh | 0.621 |
| CYP1A2-sub | 0.51 |
| CYP2c19-inh | 0.835 |
| CYP2c19-sub | 0.772 |
| CYP2c9-inh | 0.744 |
| CYP2c9-sub | 0.91 |
| CYP2d6-inh | 0.038 |
| CYP2d6-sub | 0.344 |
| CYP3a4-inh | 0.683 |
| CYP3a4-sub | 0.141 |
| CL | 6.358 |
| T12 | 0.097 |
| hERG | 0.002 |
| Ames | 0.297 |
| ROA | 0.448 |
| SkinSen | 0.964 |
| Carcinogencity | 0.459 |
| EI | 0.991 |
| Respiratory | 0.966 |
| NR-Aromatase | 0.914 |
| Antiviral | No |
| Prediction | 0.942276 |